Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

PUBLICATION DATE

6 results
Display

Metastases to Skeletal Muscles from Non-Small Cell Lung Cancer Demonstrated by 18F-FDG PET/CT

Kwon SY, Jeong SY, Min JJ, Oh IJ, Kim YC, Bom HS

Hematogenous metastases to skeletal muscles are extremely rare metastases that may present as painful masses in the proximal skeletal muscles. The reasons for the rarity of metastatic tumors in skeletal...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Lung Cancer with Acute Myocardial Infarction

Oh IJ, Kim KS, Kim YC

A 63-year-old man with recurred squamous cell lung carcinoma was admitted to our facility due to an acute onset of chest and upper back pain. He had undergone a left...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Mutational Analysis of Pro-apoptotic BNIP3 Gene in Non- Small Cell Lung Cancers

Lee SH, Lee SH

PURPOSE : Cell death deregulation is a hallmark of human cancers. BNIP3, which was initially identified as a pro-apoptotic member of the Bcl-2 family, plays an important role in apoptosis,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Compliance with Adjuvant Chemotherapy for Completely Resected Non-small Cell Lung Cancer

Lee HS, Kim MS, Lee JM, Kim HT, Hwang BR, Han DS, Ahn HK, Zo JI

PURPOSE : To evaluate the compliance of patients who underwent complete resection of non-small cell lung cancer (NSCLC) with adjuvant chemotherapy. MATERIALS AND METHODS : Between January 2004 and May...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
National Survey of Lung Cancer in Korea, 2005

Kim YC, Kwon YS, Oh IJ, Kim KS, Kim SY, Ryu JS, Yum HK, Yong SJ, Lee KH, Lee CG, Lee SY, Lee SY, Jung MH, Jeong ET, In KH

PURPOSE : Lung Cancer has been the leading cause of cancer deaths in South Korea since the year 2000, and its incidence continues to rise. Here we report the result...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Efficacy and Safety of Weekly Low Dose Paclitaxel and Cisplatin as First Line Therapy in Advanced NSCLC of Elderly Patients

Lee JH, Kwon MH, Jeoung JH, Lee GE, Choi EG, Na MJ, Cho HM, Kim YJ, Chung WK, Cho YJ, Son JW

PURPOSE : Anti-cancer chemotherapeutic agents act by inhibiting tumor cell proliferation through cytotoxic action, therefore the generally tolerated maximum dose is administered to patients. However, this often results in the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr